Within the EU project NEOBRAIN (Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants), scientists will collaborate in order to identify strategies to diagnose and to protect the newborn brain against such insults.
In NEOBRAIN, small and medium enterprises collaborate with academic research groups. The project links scientists from a total of 13 partner institutions. The involvement of the companies provides a unique opportunity for using the research results in product development without delay. Publication of project findings in high-profile journals will disseminate new research results and resulting applications on an international level. Scientific coordinator for the entire EU project NEOBRAIN is Prof. Dr. Olaf Dammann from Hannover Medical School, Germany. Patent research and press information will be coordinated in Innsbruck.Name of participating organisation (Short name,City, Country)
In addition to the worry for parents and relatives of prematurely born children, the increasing number of premature babies also has economic effects: across the EU, between six and seven billion euros per year are spent on treating premature babies. It is not possible to apply the results of medical research obtained in adults reliably to premature babies. Therefore the medical profession faces the problem that not only is there no marker for early diagnosis of brain damage, there is also no prophylaxis or therapy that protects the brain.
New approaches in research
It is precisely at this point that the NEOBRAIN comes in. The EU research project, which runs for three years, aims to:
1. find biomarkers for early brain damage. In various animal tests the mechanisms leading to brain damage will be investigated. Moreover, a clinical study of children born before the 28th week of pregnancy is planned in order to develop marker profiles.
2. develop strategies for protecting the brain. Here too animal tests will be carried out. Only the most promising results will find their way into clinical research.
3. create a clinical platform as research network for future European and international studies.
4. develop medication within the three year project period and beyond.
The results of neonatal basic research will thus feed directly into clinical research. New findings and therapeutic approaches gained in this way will be introduced rapidly into clinical practice in neonatal intensive care.NEOBRAIN budget
Mag. Uwe Steger | alfa
Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering